Our Research

24 Results Found

Research Topic: Microbicides and Multipurpose Prevention Technologies

Countries: United States

Projects: All

Journals: None

Resources: All

Key Staff: All

Years: 1978 - Present

Projects (4)

Novel Intravaginal Ring as a Non-Hormonal Contraceptive | United Kingdom, United States
An Intravaginal Ring Containing Etonogestrel, Ethinyl Estradiol, and QGriffithsin (EEQ IVR) to Prevent Pregnancy and HIV | United States
Non-hormonal Contraceptive Multipurpose Prevention Technology (MPT) Containing Q-Griffithsin | United States
Developing and Testing a Griffithsin (non-ARV) Microbicide | United States, Global Research

Key Staff (13)

Marlena Gehret Plagianos Senior Biostatistician, Center for Biomedical Research
George W. Creasy Senior Medical Advisor, Center for Biomedical Research
José Fernández-Romero Scientist II, Center for Biomedical Research
Natalia Teleshova Senior Scientist, Center for Biomedical Research
Larisa Kizima Research Investigator, Center for Biomedical Research
Barbara Friedland Associate II, New York
Loreley Villamide-Herrera Senior Manager, Business Process Transformation and Integration (BPTI) & Associate Director, Project Matrix, New York
Thomas M. Zydowsky Senior Strategic Advisor, Center for Biomedical Research
Bruce Variano Senior Scientist, Head of Pharmaceutical Development, Center for Biomedical Research
Narender Kumar Senior Scientist, Center for Biomedical Research
Sanyukta Mathur Senior Associate and DREAMS Implementation Science Project Director, Washington, DC
Lisa Haddad Medical Director, Center for Biomedical Research
Pavimol Angsantikul Pharmaceutical Development Scientist, Center for Biomedical Research

Resources (7)

News & Views NIH Center Grant to Develop First Non-Hormonal Vaginal Ring for Pregnancy and STI Prevention
Publication Date: 27 January 2022
News & Views Preclinical Study Shows Microbicide Gel’s Effectiveness Against HIV and Other Viruses
Publication Date: 21 August 2014
Journal Article A single dose of a MIV-150/zinc acetate gel provides 24 h of protection against vaginal simian human immunodeficiency virus reverse transcriptase infection, with more limited protection rectally 8-24 h after gel use
Authors: Jessica Kenney, Rachel Singer, Nina Derby, Meropi Aravantinou, Ciby J. Abraham, Radhika Menon, Samantha Seidor, Shimin Zhang, Agegnehu Gettie, James Blanchard, Michael Piatak Jr., Jeffrey D. Lifson, José Fernández-Romero, Thomas M. Zydowsky, Melissa Robbiani. AIDS Research and Human Retroviruses Publication Date: November 2012
Journal Article The nonnucleoside reverse transcription inhibitor MIV-160 delivered from an intravaginal ring, but not from a carrageenan gel, protects against simian/human immunodeficiency virus-RT infection
Authors: Meropi Aravantinou, Rachel Singer, Nina Derby, Giulia Calenda, Paul Mawson, Ciby J. Abraham, Radhika Menon, Samantha Seidor, Daniel Goldman, Jessica Kenney, Guillermo Villegas, Agegnehu Gettie, James Blanchard, Jeffrey D. Lifson, Michael Piatak Jr., José Fernández-Romero, Thomas M. Zydowsky, Natalia Teleshova, Melissa Robbiani. AIDS Research and Human Retroviruses Publication Date: 2012
Journal Article Vaginal microbicide adherence biomarkers should be validated—Authors’ reply
Authors: Stephanie Skoler-Karpoff, Barbara Friedland, Marlena Gehret Plagianos, Robin A. Maguire, Pekka Lahteenmaki. The Lancet Publication Date: 2009
Journal Article Candida albicans-induced DC activation reduces HIV amplification by DCs while increasing DC-to-T-cell spread of HIV
Authors: Laurence Vachot, Vennansha G. Williams, Julian W. Bess Jr., Jeffrey D. Lifson, Melissa Robbiani. Journal of Acquired Immune Deficiency Syndromes Publication Date: 2008
Journal Article Men’s attitudes towards a potential vaginal microbicide in Zimbabwe, Mexico and the USA
Authors: Christiana Coggins, Kelly Blanchard, Barbara Friedland. Reproductive Health Matters Publication Date: 2000

Our Research

Search Results

Projects (4)

Key Staff (13)

Resources (7)